Evidence map›Paper›PMID 29682625›Full record

ReviewTranslational gastroenterology and hepatology2018

Review of management options for pancreatic pseudocysts.

Christos Agalianos, Ioannis Passas, Ioannis Sideris, Demetrios Davides, Christos Dervenis

Abstract readReview
In one paragraph

Review in Translational gastroenterology and hepatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Outlandish pancreatic pseudocyst: A case report.Journal of family medicine and primary care · 2023
    Article
  14. Article
  15. Article
  16. Management of severe acute pancreatitis in 2019.Translational gastroenterology and hepatology · 2022
    Review
  17. Article
  18. Article
  19. Pancreatic pseudocyst: Dilemma of its recent management (Review).Experimental and therapeutic medicine · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Christos AgalianosDepartment of Surgery, Athens Naval and Veterans Hospital, Athens, Greece.
Ioannis PassasDepartment of Surgery, Metropolitan Hospital of Athens, Athens, Greece.
Ioannis SiderisDepartment of Surgery, Metropolitan Hospital of Athens, Athens, Greece.
Demetrios DavidesDepartment of Surgery, Metropolitan Hospital of Athens, Athens, Greece.
Christos DervenisDepartment of Surgery, Metropolitan Hospital of Athens, Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pancreatic pseudocysts (PPs) present a challenging problem for physicians dealing with pancreatic disorders. Their management demands the co-operation of surgeons, radiologists and gastroenterologists. Historically, they have been treated either conservatively or surgically, with acceptable rates of complications and recurrence. However, recent advances in radiology and endoscopy, have leaded physicians to implement percutaneous and endoscopic drainage (ED) into their treatment algorithms. Moreover, laparoscopic surgery, with its advantages, has become an attractive alternative choice when surgical drainage (SD) is required. The aim of this review is to summarize the main diagnostic and therapeutic tools in the management of pseudocysts and to present the main studies that compare the three different types of pseudocyst drainage.

Indexed as

drainageManagementpseudocyst

Identifiers

PMID29682625
PMCPMC5897675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.